Aurobindo Pharma Financials
NSE: AUROPHARMA | BSE: 524804
₹1,653.10
₹15.80
(0.97%)
As on 04-Sep-2026 15:52IST
Market cap
₹95,127 Cr
Revenue (TTM)
₹34,935 Cr
P/E Ratio
25.6
P/B Ratio
2.4
Div. Yield
0.2 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
34,935.29
|
33,653.08
|
31,723.73
|
29,001.87
|
24,855.38
|
23,455.49
|
|
|
|
|
|
|
Total Income
|
35,624.79
|
34,173.57
|
32,345.58
|
29,559.25
|
25,145.97
|
23,778.07
|
|
|
|
|
|
|
Total Expenditure
|
27,850.01
|
26,835.75
|
25,140.94
|
23,158.87
|
21,136.74
|
19,070.95
|
|
|
|
|
|
|
EBITDA
|
7,085.28
|
6,817.33
|
6,582.79
|
5,843.00
|
3,718.64
|
4,384.54
|
|
|
|
|
|
|
Depreciation
|
1,859.31
|
1,778.19
|
1,649.42
|
1,521.66
|
1,244.58
|
1,126.52
|
|
|
|
|
|
|
EBIT
|
5,225.97
|
5,039.14
|
4,933.37
|
4,321.34
|
2,474.06
|
3,258.02
|
|
|
|
|
|
|
Interest
|
387.88
|
383.97
|
457.24
|
289.71
|
140.48
|
48.64
|
|
|
|
|
|
|
Other Income
|
689.50
|
520.49
|
621.85
|
557.38
|
290.59
|
322.58
|
|
|
|
|
|
|
Exceptional Items
|
-105.51
|
-65.33
|
--
|
-191.86
|
--
|
-127.97
|
|
|
|
|
|
|
Profit before Tax
|
5,422.08
|
5,111.85
|
5,066.29
|
4,379.99
|
2,612.50
|
3,372.74
|
|
|
|
|
|
|
Provision for Tax
|
1,709.34
|
1,608.88
|
1,582.72
|
1,211.02
|
684.85
|
725.63
|
|
|
|
|
|
|
Profit after Tax
|
3,712.74
|
3,502.97
|
3,483.57
|
3,168.97
|
1,927.65
|
2,647.11
|
|
|
|
|
|
|
Minority Interest
|
1.76
|
1.78
|
2.31
|
4.00
|
-0.15
|
1.04
|
|
|
|
|
|
|
Share of Associate
|
-1.94
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
3,712.56
|
3,504.75
|
3,485.88
|
3,172.97
|
1,927.50
|
2,648.15
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
37,890.97
|
37,890.97
|
32,653.32
|
29,842.80
|
26,839.85
|
24,575.98
|
|
|
|
|
|
|
Minority Interest
|
1.76
|
-8.16
|
-6.39
|
8.00
|
12.00
|
-1.93
|
|
|
|
|
|
|
Non-Current Liabilities
|
2,580.33
|
1,096.74
|
1,162.74
|
1,808.94
|
866.87
|
903.10
|
|
|
|
|
|
|
Current Liabilities
|
18,039.01
|
18,039.01
|
14,682.34
|
12,199.13
|
11,493.78
|
8,155.98
|
|
|
|
|
|
|
Total Liabilities
|
58,502.15
|
58,196.15
|
49,481.70
|
44,714.95
|
39,500.38
|
33,633.13
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
24,040.45
|
24,309.81
|
21,329.55
|
19,653.24
|
17,666.83
|
15,510.44
|
|
|
|
|
|
|
Current Assets
|
32,708.75
|
32,708.75
|
27,162.46
|
23,771.92
|
21,459.91
|
18,043.59
|
|
|
|
|
|
|
Total Assets
|
58,502.15
|
58,196.15
|
49,481.70
|
44,714.95
|
39,500.38
|
33,633.13
|
|
|
|
|
|
|
Total Debt*
|
--
|
7,676.20
|
7,941.68
|
6,315.22
|
4,861.52
|
2,372.77
|
|
|
|
|
|
|
Net Current Assets
|
14,669.74
|
14,669.74
|
12,480.12
|
11,572.79
|
9,966.13
|
9,887.61
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
1,358.37
|
1,290.26
|
311.34
|
158.53
|
157.74
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
5,526.37
|
3,924.62
|
2,434.52
|
2,386.75
|
5,016.48
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-3,458.61
|
-1,875.80
|
-4,255.95
|
-3,977.75
|
-3,211.56
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-1,269.15
|
119.78
|
800.42
|
1,814.41
|
-2,969.27
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
798.61
|
2,168.60
|
-1,021.01
|
223.41
|
-1,164.35
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
65.33
|
60.34
|
60.02
|
54.16
|
32.90
|
45.20
|
|
|
|
|
|
|
Cash EPS (₹)
|
64.52
|
90.93
|
88.38
|
80.06
|
54.14
|
64.41
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
676.49
|
652.39
|
562.21
|
509.35
|
458.10
|
419.46
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.24
|
4.00
|
--
|
4.50
|
3.00
|
9.00
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
95.15
|
67.57
|
41.55
|
40.74
|
85.62
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
40.30
|
23.57
|
-9.32
|
-10.98
|
44.83
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
12.76
|
14.39
|
13.76
|
9.39
|
12.71
|
|
|
|
|
|
|
ROE (%)
|
10.38
|
9.93
|
11.15
|
11.18
|
7.50
|
11.38
|
|
|
|
|
|
|
ROA (%)
|
6.86
|
6.64
|
7.54
|
7.63
|
5.29
|
7.90
|
|
|
|
|
|
|
EBIT Margin (%)
|
14.96
|
14.97
|
15.55
|
14.90
|
9.95
|
13.89
|
|
|
|
|
|
|
Net Margin (%)
|
10.42
|
10.25
|
10.77
|
10.72
|
7.67
|
11.13
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
7.60
|
8.08
|
7.85
|
6.24
|
7.89
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
9.09
|
6.08
|
9.39
|
16.68
|
5.97
|
-5.32
|
|
|
|
|
|
|
EBIT Growth (%)
|
6.91
|
2.14
|
14.16
|
74.67
|
-24.06
|
-23.84
|
|
|
|
|
|
|
Net Profit Growth (%)
|
11.59
|
0.56
|
9.93
|
64.40
|
-27.18
|
-50.37
|
|
|
|
|
|
|
EPS Growth (%)
|
9.76
|
0.54
|
10.83
|
64.62
|
-27.21
|
-50.36
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
16.04
|
9.42
|
11.19
|
9.21
|
12.07
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
25.62
|
21.60
|
19.32
|
20.12
|
15.75
|
14.80
|
|
|
|
|
|
|
Price / Book Value
|
2.44
|
2.00
|
2.06
|
2.14
|
1.13
|
1.59
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.24
|
0.31
|
--
|
0.41
|
0.58
|
1.35
|
|
|
|
|
|
|
EV/EBITDA
|
11.95
|
10.02
|
9.31
|
9.98
|
7.27
|
7.94
|
|
|
|
|
|
|
Close Price (₹)
|
1,578.70
|
1,304.40
|
1,160.50
|
1,088.75
|
518.10
|
668.55
|
|
|
|
|
|
|
High Price (₹)
|
1,588.90
|
1,330.90
|
1,592.55
|
1,177.10
|
714.70
|
1,063.90
|
|
|
|
|
|
|
Low Price (₹)
|
1,016.10
|
994.35
|
1,030.65
|
504.65
|
397.20
|
584.20
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
95,127.23
|
75,689.14
|
67,355.82
|
63,830.22
|
30,348.42
|
39,193.77
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.02
|
0.20
|
0.24
|
0.21
|
0.18
|
0.10
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.16
|
0.17
|
0.14
|
0.16
|
0.09
|
|
|
|
|
|
|
Current Ratio
|
1.81
|
1.81
|
1.85
|
1.95
|
1.87
|
2.21
|
|
|
|
|
|
|
Quick Ratio
|
1.15
|
1.15
|
1.13
|
1.14
|
1.13
|
1.29
|
|
|
|
|
|
|
Interest Coverage
|
14.98
|
14.31
|
12.08
|
16.12
|
19.60
|
70.34
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
20.31
|
21.08
|
18.11
|
16.61
|
17.97
|
17.11
|
|
|
|
|
|
|
Asset Turnover
|
0.65
|
1.32
|
1.38
|
1.44
|
1.40
|
1.43
|
|
|
|
|
|
|
Receivable days
|
--
|
33.71
|
30.33
|
28.34
|
30.42
|
28.69
|
|
|
|
|
|
|
Inventory Days
|
--
|
59.32
|
58.44
|
55.92
|
57.65
|
63.29
|
|
|
|
|
|
|
Payable days
|
--
|
148.20
|
135.14
|
133.88
|
117.74
|
108.60
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
-55.17
|
-46.37
|
-49.62
|
-29.67
|
-16.62
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
